Understanding the Popularity of Unlicensed Medical Cannabis Providers in Thailand In Thailand, the use of medical cannabis from unlicensed providers continues to thrive, despite the availability of licensed clinics. A recent qualitative study investigates the reasons behind this phenomenon, shedding light on patient preferences and perceptions. This article delves into Read more…
This comprehensive study, available on PubMed Central, examines the potential of targeting endocannabinoid degradation enzyme inhibitors for the development of new antipsychotic medications. Schizophrenia and other psychotic disorders often lack effective treatments with minimal side effects, driving the need for innovative approaches. The endocannabinoid system, known for its role in Read more…
Recent research published under the title “Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients” has revealed promising results regarding the use of medical cannabis among those undergoing palliative care for cancer. The study, accessible through the National Center for Biotechnology Information (NCBI), indicates significant improvements in Read more…
Schizophrenia and related psychotic disorders pose significant challenges in contemporary psychiatry, necessitating the exploration of novel therapeutic approaches. Recent research has turned towards the endocannabinoid system and its role in psychiatric disorders. Notably, endocannabinoid degradation enzyme inhibitors have emerged as potential antipsychotics, promising a new frontier in medicinal chemistry. The Read more…
Recent research has highlighted the significant therapeutic potential of Cannabidiol (CBD) in managing social stress and enhancing emotional support among patients. This summary delves into the comprehensive study published in the National Center for Biotechnology Information (NCBI), which investigates how CBD interacts with our mental health, particularly in the context Read more…
Parkinsonβs disease (PD) is a progressive neurodegenerative disorder marked by the loss of dopamine-producing neurons in the brain, leading to motor and non-motor symptoms. Recent research has explored the therapeutic potential of cannabidiol (CBD), a non-psychoactive compound found in cannabis, in treating PD. A study published in the PubMed Central Read more…
Arthritis, characterized by debilitating inflammation and chronic pain, significantly impacts the quality of life for millions globally. Recent research has highlighted a promising therapeutic approach using transdermal cannabidiol (CBD). In a study published by NCBI, the efficacy of transdermal CBD in reducing inflammation and pain-related behaviors associated with arthritis was Read more…
Cannabidiol (CBD), a non-psychoactive compound found in cannabis, has garnered significant attention due to its potential therapeutic effects across a variety of conditions. One of the critical pathways through which CBD exerts these effects is by enhancing anandamide signaling within the endocannabinoid system (ECS). The ECS is a complex cell-signaling Read more…
In a groundbreaking study published in the National Center for Biotechnology Information, researchers delve deep into the multifaceted benefits of cannabis and its derived compounds, especially focusing on their antimicrobial properties and how these attributes could mark a turning point in the treatment of neurodegenerative diseases through CB2 receptor targeting. Read more…
The intriguing world of cannabinoids has been the subject of scientific fascination for its multifaceted effects on the human body and mind. Recently, the spotlight has turned towards understanding how these natural compounds affect sleep and whether they hold the key to treating sleep disorders. The comprehensive study published in Read more…